Garp as a biomarker and biotarget in t-cell malignancies
US-2026029402-A1 · Jan 29, 2026 · US
This page is not indexed by search engines while we improve data quality.
Ortonne Nicolas patents
Ortonne Nicolas is listed as an inventor on 4 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Ortonne Nicolas |
| Total patents | 4 |
| First publication | May 12, 2016 |
| Latest publication | Jan 29, 2026 |
Notable patents
Publications ranked by popularity score, then publication date.
Methods for the diagnosis and treatment of t cell-lymphomas
US-2024175873-A1 · May 30, 2024 · US
Kir3dl2 is a biomarker and a therapeutic target useful for respectively preventing and treating a subset of cutaneous and non-cutaneous peripheral t-cell lymphomas
US-2018291102-A1 · Oct 11, 2018 · US
Kir3dl2 is a biomarker and a therapeutic target useful for respectively preventing and treating a subset of cutaneous and non-cutaneous peripheral t-cell lymphomas
US-2016130346-A1 · May 12, 2016 · US
Recent patents
Latest publications not already listed above.
No data yet.
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Inst Nat Sante Rech Med | 4 |
| Univ Paris Val De Marne | 4 |
| Hopitaux Paris Assist Publique | 3 |
| Univ Paris Diderot Paris 7 | 2 |
| Univ Paris Cite | 2 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| G01N33/57505 | 4 |
| G01N33/57426 | 4 |
| C07K2317/73 | 3 |
| A61P35/02 | 3 |
| C12N15/117 | 2 |